Potentially Inappropriate Medications (PIMs) in Geriatric Outpatients Prescriptions in Yogyakarta: Pattern and Factors Related to Occurrences
Keywords:
Potentially inappropriate medication, Multimorbidity, Polypharmacy
Abstract
Potentially Inappropriate Medications (PIMs) were commonly found in geriatric patients’ prescriptions and widely assessed using Beer’s Criteria and STOPP/START tool. In this study we aimed to assess the patterns of PIMs in geriatric outpatients in Yogyakarta, Indonesia and the factors related to the occurrence. This study was using retrospective observational design and conducted at two teaching hospitals in Yogyakarta, Indonesia. The data source included medical records of the outpatients aged 60 years during August to October 2022. The criteria used to evaluate PIMs from the prescriptions were the 2019 AGS Beers® Criteria and STOPP_INA tool based on the STOPP/START version 2 tool. Several predictors, including multimorbidity, polypharmacy, age, gender, health insurance, and working status, were analyzed using a logistic regression model. Out of the 393 subjects included in this study, 193 cases of PIMs were identified in 135 patients (34.35%), with a total of 67 cases according to the Beers Criteria and 141 cases according to STOPP_INA. Aspirin and benzodiazepines were found to be the drugs causing most of PIMs in geriatric patients. Polypharmacy emerged as the strongest predictors of PIM occurrence (p<0.05). The prevalence of PIMs in outpatient geriatric prescriptions at Yogyakarta Hospital was notably influenced by polypharmacy. Therefore, there is a pressing need for vigilant monitoring and meticulous drug selection when prescribing for the elderly population to mitigate the potential risks associated with PIMs.
References
Abdulah, R., Insani, W. N., Destiani, D., Rohmaniasari, N., Mohenathas, N., & Barliana, M. I. (2018). Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Therapeutics and Clinical Risk Management, Volume 14, 1591–1597. https://doi.org/10.2147/TCRM.S170475
Achterhof, A. B., Rozsnyai, Z., Reeve, E., Jungo, K. T., Floriani, C., Poortvliet, R. K. E., Rodondi, N., Gussekloo, J., & Streit, S. (2020). Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLOS ONE, 15(10), e0240463. https://doi.org/10.1371/journal.pone.0240463
Alhawassi, T. M., Alatawi, W., & Alwhaibi, M. (2019). Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatrics, 19(1), 154. https://doi.org/10.1186/s12877-019-1168-1
Almeida, T. A., Reis, E. A., Pinto, I. V. L., Ceccato, M. das G. B., Silveira, M. R., Lima, M. G., & Reis, A. M. M. (2019). Factors associated with the use of potentially inappropriate medications by older adults in primary health care: An analysis comparing AGS Beers, EU(7)-PIM List , and Brazilian Consensus PIM criteria. Research in Social and Administrative Pharmacy, 15(4), 370–377. https://doi.org/10.1016/j.sapharm.2018.06.002
Alshammari, H., Al-Saeed, E., Ahmed, Z., & Aslanpour, Z. (2021). Reviewing Potentially Inappropriate Medication in Hospitalized Patients Over 65 Using Explicit Criteria: A Systematic Literature Review. Drug, Healthcare and Patient Safety, Volume 13, 183–210. https://doi.org/10.2147/DHPS.S303101
Alyazeedi, A., Fouad Algendy, A., Sharabash, M., & Karawia, A. (2019). Prevalence, Determinants And Associated Risk Of Potentially Inappropriate Prescribing For Older Adults In Qatar: A National Retrospective Study. Clinical Interventions in Aging, Volume 14, 1889–1899. https://doi.org/10.2147/CIA.S222532
American Geriatrics Society. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults: 2019 AGS BEERS CRITERIA® UPDATE EXPERT PANEL. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
Atmaja, D. S., Yulistiani, Suharjono, & Zairina, E. (2022). Detection tools for prediction and identification of adverse drug reactions in older patients: A systematic review and meta-analysis. Scientific Reports, 12(1), 13189. https://doi.org/10.1038/s41598-022-17410-w
Bhagavathula, A. S., Gebreyohannes, E. A., & Fialova, D. (2022). Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis. Gerontology, 68(2), 136–145. https://doi.org/10.1159/000516075
Castellana, C., Pecere, S., Furnari, M., Telese, A., Matteo, M. V., Haidry, R., & Eusebi, L. H. (2021). Side effects of long-term use of proton pump inhibitors: Practical considerations. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.15997
Chang, C. T., Teoh, S. L., Rajan, P., & Lee, S. W. H. (2023). Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review. Research in Social and Administrative Pharmacy, 19(8), 1146–1156. https://doi.org/10.1016/j.sapharm.2023.05.017
Chen, Q., & Zhang, L. (2021). Analysis of potentially inappropriate medications (PIM) used in elderly outpatients in departments of internal medicine by using the Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) criteria. Annals of Palliative Medicine, 10(4), 4678–4686. https://doi.org/10.21037/apm-21-799
Chou, L., Kuo, Y., Raji, M. A., & Goodwin, J. S. (2021). Potentially inappropriate medication prescribing by nurse practitioners and physicians. Journal of the American Geriatrics Society, 69(7), 1916–1924. https://doi.org/10.1111/jgs.17120
Clark, C. M., Shaver, A. L., Aurelio, L. A., Feuerstein, S., Wahler, R. G., Daly, C. J., & Jacobs, D. M. (2020). Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs. Journal of the American Geriatrics Society, 68(11), 2542–2550. https://doi.org/10.1111/jgs.16743
Curtin, D., Gallagher, P. F., & O’Mahony, D. (2019). Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Therapeutic Advances in Drug Safety, 10, 204209861982943. https://doi.org/10.1177/2042098619829431
Davies, S. J., Rudoler, D., de Oliveira, C., Huang, A., Kurdyak, P., & Iaboni, A. (2022). Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study. Journal of Psychopharmacology, 36(4), 460–469. https://doi.org/10.1177/02698811211069096
Díez, R., Cadenas, R., Susperregui, J., Sahagún, A. M., Fernández, N., García, J. J., Sierra, M., & López, C. (2022). Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study. Journal of Clinical Medicine, 11(13), 3808. https://doi.org/10.3390/jcm11133808
Erraez, S., López-Mesa, M., & Gómez-Fernández, P. (2021). Mineralcorticoid receptor blockers in chronic kidney disease. Nefrología (English Edition), 41(3), 258–275. https://doi.org/10.1016/j.nefroe.2021.08.001
Fauziyah, S., Andrajati, R., Sartika, R. D., & Radji, M. (2020). Adaptation and validation of the screening tool of older people’s prescriptions instrument for the Indonesian population. Journal of Research in Pharmacy Practice, 9(1), 24. https://doi.org/10.4103/jrpp.JRPP_19_106
Haastrup, P. F., Thompson, W., Søndergaard, J., & Jarbøl, D. E. (2018). Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology, 123(2), 114–121. https://doi.org/10.1111/bcpt.13023
Hao, Q., Tampi, M., O’Donnell, M., Foroutan, F., Siemieniuk, R. A., & Guyatt, G. (2018). Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: Systematic review and meta-analysis. BMJ, k5108. https://doi.org/10.1136/bmj.k5108
Hill-Taylor, B., Walsh, K. A., Steward, S., Hayden, J., Byrne, S., & Sketris, I. S. (2016). Effectiveness of the STOPP/START (Screening Tool of Older Persons’potentiallyinappropriate Prescriptions/Screening Tool to Alert doctors to the RightTreatment) criteria: Systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther, 41, 158–169. https://doi.org/10.1111/jcpt.12372
Hussain, M. A., Huxley, R. R., & Al Mamun, A. (2015). Multimorbidity prevalence and pattern in Indonesian adults: An exploratory study using national survey data. BMJ Open, 5(12), e009810. https://doi.org/10.1136/bmjopen-2015-009810
Jaynes, M., & Kumar, A. B. (2019). The risks of long-term use of proton pump inhibitors: A critical review. Therapeutic Advances in Drug Safety, 10, 204209861880992. https://doi.org/10.1177/2042098618809927
Jung, S. J., Kim, B. J., Kim, C. K., Shim, S. R., & Jung, J.-M. (2022). Antiplatelet regimens after ischemic stroke or transient ischemic attack: A systematic review and updated network meta-analysis. Annals of Translational Medicine, 10(5), 245–245. https://doi.org/10.21037/atm-21-3748
Jungo, K. T., Streit, S., & Lauffenburger, J. C. (2021). Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications. BMC Geriatrics, 21(1), 163. https://doi.org/10.1186/s12877-021-02089-x
Koçak, F. Ö. K., Taşkıran, E., Öztürk, Z. K., & Şahin, S. (2022). Potentially Inappropriate Medication Use among Nursing Home Residents: Medication Errors Associated with Pro re nata Medications and the Importance of Pill Burden. Annals of Geriatric Medicine and Research, 26(3), 233–240. https://doi.org/10.4235/agmr.22.0096
Kojima, T. (2018). The Need for Actions Against Polypharmacy in Older People With Frailty. Annals of Geriatric Medicine and Research, 22(3), 111–116. https://doi.org/10.4235/agmr.2018.22.3.111
Komagamine, J. (2018). Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: A retrospective cross-sectional study. BMJ Open, 8(7), e021152. https://doi.org/10.1136/bmjopen-2017-021152
Lemeshow, S., Hosmer, D. W., Klar, J., & Lwanga, S. K. (1990). Adequacy of Sample Size in Health Studies. John Wiley & Sons.
Lisowska, A., Czepielewska, E., Rydz, M., Dworakowska, A., Makarewicz-Wujec, M., & Kozłowska-Wojciechowska, M. (2022). Applicability of tools to identify potentially inappropriate prescribing in elderly during medication review: Comparison of STOPP/START version 2, Beers 2019, EU(7)-PIM list, PRISCUS list, and Amsterdam tool—A pilot study. PLOS ONE, 17(9), e0275456. https://doi.org/10.1371/journal.pone.0275456
Liu, L., Jia, L., Jian, P., Zhou, Y., Zhou, J., Wu, F., & Tang, Y. (2020). The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies. Frontiers in Psychiatry, 11, 00755. https://doi.org/10.3389/fpsyt.2020.00755
Louvet, S., Ischayek, M., & Danoff, R. (2015). The Current Role of Long-Term Benzodiazepines for the Treatment of Generalized Anxiety. Osteopathic Family Physician, 7(1).
M. Meraya, A., Alwhaibi, M., H Syed, M., Shwihi, A., Mashraqi, M., Tripathi, R., Buayti, Y., & Moraya, D. (2020). Utilization of Psychotropic Medications and Polypharmacy Among Adults in Jazan Region, Saudi Arabia. Indonesian Journal of Pharmacy, 205. https://doi.org/10.22146/ijp.813
Ma, Z., Zhang, C., Cui, X., & Liu, L. (2018). Comparison of three criteria for potentially inappropriate medications in Chinese older adults. Clinical Interventions in Aging, Volume 14, 65–72. https://doi.org/10.2147/CIA.S190983
Magalhães, M. S., Santos, F. S. dos, & Reis, A. M. M. (2019). Factors associated with the use of potentially inappropriate medication by elderly patients prescribed at hospital discharge. Einstein (São Paulo), 18, eAO4877. https://doi.org/10.31744/einstein_journal/2020AO4877
Masudo C., Ogawa Y., Yamashita N., & Mihara K. (2019). Association between Elimination Half-life of Benzodiazepines and Falls in the Elderly: A Meta-analysis of Observational Studies. YAKUGAKU ZASSHI, 139(1), 113–122. https://doi.org/10.1248/yakushi.18-00156
Miller, G. E., Sarpong, E. M., Davidoff, A. J., Yang, E. Y., Brandt, N. J., & Fick, D. M. (2017). Determinants of Potentially Inappropriate Medication Use among Community-Dwelling Older Adults. Health Services Research, 52(4), 1534–1549. https://doi.org/10.1111/1475-6773.12562
Monteiro, C., Silvestre, S., Duarte, A. P., & Alves, G. (2022). Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. International Journal of Environmental Research and Public Health, 19(6), 3541. https://doi.org/10.3390/ijerph19063541
Nurmainah, N., & Astuti, R. (2022). Detection of Potentially Inappropriate Medication in Elderly Outpatient Based on The Beer’s Criteria 2019. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA, 9(1), 82–91. https://doi.org/10.20473/jfiki.v9i12022.82-91
Oliveira, M. G., Amorim, W. W., de Jesus, S. R., Heine, J. M., Coqueiro, H. L., & Passos, L. C. S. (2015). A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care: Beers or STOPP criteria in primary care. Journal of Evaluation in Clinical Practice, 21(2), 320–325. https://doi.org/10.1111/jep.12319
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan, C., & Gallagher, P. (2014). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age and Ageing, 44(2), 213–218. https://doi.org/10.1093/ageing/afu145
Pergolizzi, J. V., & LeQuang, J. A. (2020). Reappraising the use of benzodiazepines in chronic pain patients. Postgraduate Medicine, 132(sup3), 10–12. https://doi.org/10.1080/00325481.2020.1725352
Perpétuo, C., Plácido, A. I., Rodrigues, D., Aperta, J., Piñeiro-Lamas, M., Figueiras, A., Herdeiro, M. T., & Roque, F. (2021). Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria. Frontiers in Pharmacology, 12, 676020. https://doi.org/10.3389/fphar.2021.676020
Rahmawati, F., Mustafidah, N., Pramantara, I. D. P., & Wahab, I. A. (2019). A Study of Psychoactive Medicines and Risk of Falls Among Indonesian Elderly Patients. Indonesian Journal of Pharmacy, 30(3), 233. https://doi.org/10.14499/indonesianjpharm30iss3pp233
Reimers, M., Eriksdotter, M., Seiger, Å., & Fastbom, J. (2018). Prescription Changes During Geriatric Care Episodes: A Trend Analysis Conducted in Sweden. Drugs & Aging, 35(3), 243–248. https://doi.org/10.1007/s40266-017-0509-z
Renom-Guiteras, A., Meyer, G., & Thürmann, P. A. (2015). The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries. European Journal of Clinical Pharmacology, 71(7), 861–875. https://doi.org/10.1007/s00228-015-1860-9
Salive, M. E. (2013). Multimorbidity in Older Adults. Epidemiologic Reviews, 35(1), 75–83. https://doi.org/10.1093/epirev/mxs009
Samara, M. T., Huhn, M., Chiocchia, V., Schneider‐Thoma, J., Wiegand, M., Salanti, G., & Leucht, S. (2020). Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: A systematic review and network meta‐analysis. Acta Psychiatrica Scandinavica, 142(1), 6–17. https://doi.org/10.1111/acps.13201
San-José, A., Agustí, A., Vidal, X., Formiga, F., Gómez-Hernández, M., García, J., López-Soto, A., Ramírez-Duque, N., Torres, O. H., Barbé, J., & on behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project. (2015). Inappropriate prescribing to the oldest old patients admitted to hospital: Prevalence, most frequently used medicines, and associated factors. BMC Geriatrics, 15(1), 42. https://doi.org/10.1186/s12877-015-0038-8
Sheth, A., Dave, R., Rana, D., & Sheth, D. (2020). Comparison of the extent and prevalence of prescription of potentially inappropriate medications prescribed to geriatric age group residing in old-age homes versus those receiving care from tertiary care hospital using Beers criteria. Perspectives in Clinical Research, 11(4), 144. https://doi.org/10.4103/picr.PICR_144_18
Soejono, C. H., & Rizka, A. (2021). Polypharmacy and Drug Use Pattern among Indonesian Elderly Patients Visiting Emergency Unit. Acta Med Indones, 53(1).
Tian, F., Chen, Z., & Wu, J. (2022). Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 13, 862561. https://doi.org/10.3389/fphar.2022.862561
Veronese, N., Demurtas, J., Thompson, T., Solmi, M., Pesolillo, G., Celotto, S., Barnini, T., Stubbs, B., Maggi, S., Pilotto, A., Onder, G., Theodoratou, E., Vaona, A., Firth, J., Smith, L., Koyanagi, A., Ioannidis, J. P. A., & Tzoulaki, I. (2020). Effect of low‐dose aspirin on health outcomes: An umbrella review of systematic reviews and meta‐analyses. British Journal of Clinical Pharmacology, 86(8), 1465–1475. https://doi.org/10.1111/bcp.14310
Villa-Zapata, L., Carhart, B. S., Horn, J. R., Hansten, P. D., Subbian, V., Gephart, S., Tan, M., Romero, A., & Malone, D. C. (2021). Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis. American Journal of Health-System Pharmacy, 78(24), 2245–2255. https://doi.org/10.1093/ajhp/zxab215
Viviandhari, D., Nurhasnah, N., Sakinah, R. N., & Wulandari, D. (2022). A Comparison of Potentially Inappropriate Medications Identification Using Beers and STOPP Criteria in Hospitalized Geriatric Patients in Jakarta. Indonesian Journal of Clinical Pharmacy, 11(2), 105–115. https://doi.org/10.15416/ijcp.2022.11.2.105
Viviandhari, D., Wulandari, N., Rusdi, N. K., Rahmi, N., Hildayana, N., & Faniroh, N. S. S. (2020). Assessing Potentially Inappropriate Medications in Hospitalized Geriatric Patients in 2 Hospital in Jakarta using STOPP START Criteria. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 10(1). https://doi.org/10.22146/jmpf.48944
Weir, R. A. P., McMurray, J. J. V., Puu, M., Solomon, S. D., Olofsson, B., Granger, C. B., Yusuf, S., Michelson, E. L., Swedberg, K., Pfeffer, M. A., & CHARM Investigators. (2008). Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa. European Journal of Heart Failure, 10(2), 157–163. https://doi.org/10.1016/j.ejheart.2007.12.006
Witenko, C., Moorman-Li, R., Motycka, C., Duane, K., Hincapie-Castillo, J., Leonard, P., & Valaer, C. (2014). Considerations for the Appropriate Use of Skeletal Muscle Relaxants for the Management Of Acute Low Back Pain. Pharmacy and Therapeutics, 39(6), 427–435.
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018). A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging and Disease, 9(1), 143. https://doi.org/10.14336/AD.2017.0306
Wulansari, A., Wiedyaningsih, C., & Probosuseno, P. (2023). Potentially Inappropriate Medication (PIM) pada Pasien Geriatri Rawat Inap di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Majalah Farmaseutik, 19(1), 91. https://doi.org/10.22146/farmaseutik.v19i1.70420
Zhang, H., Wong, E. L., Wong, S. Y., Chau, P. Y., Yip, B. H., Chung, R. Y., Lee, E. K., Lai, F. T., & Yeoh, E.-K. (2021). Prevalence and determinants of potentially inappropriate medication use in Hong Kong older patients: A cross-sectional study. BMJ Open, 11(7), e051527. https://doi.org/10.1136/bmjopen-2021-051527
Achterhof, A. B., Rozsnyai, Z., Reeve, E., Jungo, K. T., Floriani, C., Poortvliet, R. K. E., Rodondi, N., Gussekloo, J., & Streit, S. (2020). Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLOS ONE, 15(10), e0240463. https://doi.org/10.1371/journal.pone.0240463
Alhawassi, T. M., Alatawi, W., & Alwhaibi, M. (2019). Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatrics, 19(1), 154. https://doi.org/10.1186/s12877-019-1168-1
Almeida, T. A., Reis, E. A., Pinto, I. V. L., Ceccato, M. das G. B., Silveira, M. R., Lima, M. G., & Reis, A. M. M. (2019). Factors associated with the use of potentially inappropriate medications by older adults in primary health care: An analysis comparing AGS Beers, EU(7)-PIM List , and Brazilian Consensus PIM criteria. Research in Social and Administrative Pharmacy, 15(4), 370–377. https://doi.org/10.1016/j.sapharm.2018.06.002
Alshammari, H., Al-Saeed, E., Ahmed, Z., & Aslanpour, Z. (2021). Reviewing Potentially Inappropriate Medication in Hospitalized Patients Over 65 Using Explicit Criteria: A Systematic Literature Review. Drug, Healthcare and Patient Safety, Volume 13, 183–210. https://doi.org/10.2147/DHPS.S303101
Alyazeedi, A., Fouad Algendy, A., Sharabash, M., & Karawia, A. (2019). Prevalence, Determinants And Associated Risk Of Potentially Inappropriate Prescribing For Older Adults In Qatar: A National Retrospective Study. Clinical Interventions in Aging, Volume 14, 1889–1899. https://doi.org/10.2147/CIA.S222532
American Geriatrics Society. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults: 2019 AGS BEERS CRITERIA® UPDATE EXPERT PANEL. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
Atmaja, D. S., Yulistiani, Suharjono, & Zairina, E. (2022). Detection tools for prediction and identification of adverse drug reactions in older patients: A systematic review and meta-analysis. Scientific Reports, 12(1), 13189. https://doi.org/10.1038/s41598-022-17410-w
Bhagavathula, A. S., Gebreyohannes, E. A., & Fialova, D. (2022). Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis. Gerontology, 68(2), 136–145. https://doi.org/10.1159/000516075
Castellana, C., Pecere, S., Furnari, M., Telese, A., Matteo, M. V., Haidry, R., & Eusebi, L. H. (2021). Side effects of long-term use of proton pump inhibitors: Practical considerations. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.15997
Chang, C. T., Teoh, S. L., Rajan, P., & Lee, S. W. H. (2023). Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review. Research in Social and Administrative Pharmacy, 19(8), 1146–1156. https://doi.org/10.1016/j.sapharm.2023.05.017
Chen, Q., & Zhang, L. (2021). Analysis of potentially inappropriate medications (PIM) used in elderly outpatients in departments of internal medicine by using the Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) criteria. Annals of Palliative Medicine, 10(4), 4678–4686. https://doi.org/10.21037/apm-21-799
Chou, L., Kuo, Y., Raji, M. A., & Goodwin, J. S. (2021). Potentially inappropriate medication prescribing by nurse practitioners and physicians. Journal of the American Geriatrics Society, 69(7), 1916–1924. https://doi.org/10.1111/jgs.17120
Clark, C. M., Shaver, A. L., Aurelio, L. A., Feuerstein, S., Wahler, R. G., Daly, C. J., & Jacobs, D. M. (2020). Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs. Journal of the American Geriatrics Society, 68(11), 2542–2550. https://doi.org/10.1111/jgs.16743
Curtin, D., Gallagher, P. F., & O’Mahony, D. (2019). Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Therapeutic Advances in Drug Safety, 10, 204209861982943. https://doi.org/10.1177/2042098619829431
Davies, S. J., Rudoler, D., de Oliveira, C., Huang, A., Kurdyak, P., & Iaboni, A. (2022). Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study. Journal of Psychopharmacology, 36(4), 460–469. https://doi.org/10.1177/02698811211069096
Díez, R., Cadenas, R., Susperregui, J., Sahagún, A. M., Fernández, N., García, J. J., Sierra, M., & López, C. (2022). Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study. Journal of Clinical Medicine, 11(13), 3808. https://doi.org/10.3390/jcm11133808
Erraez, S., López-Mesa, M., & Gómez-Fernández, P. (2021). Mineralcorticoid receptor blockers in chronic kidney disease. Nefrología (English Edition), 41(3), 258–275. https://doi.org/10.1016/j.nefroe.2021.08.001
Fauziyah, S., Andrajati, R., Sartika, R. D., & Radji, M. (2020). Adaptation and validation of the screening tool of older people’s prescriptions instrument for the Indonesian population. Journal of Research in Pharmacy Practice, 9(1), 24. https://doi.org/10.4103/jrpp.JRPP_19_106
Haastrup, P. F., Thompson, W., Søndergaard, J., & Jarbøl, D. E. (2018). Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology, 123(2), 114–121. https://doi.org/10.1111/bcpt.13023
Hao, Q., Tampi, M., O’Donnell, M., Foroutan, F., Siemieniuk, R. A., & Guyatt, G. (2018). Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: Systematic review and meta-analysis. BMJ, k5108. https://doi.org/10.1136/bmj.k5108
Hill-Taylor, B., Walsh, K. A., Steward, S., Hayden, J., Byrne, S., & Sketris, I. S. (2016). Effectiveness of the STOPP/START (Screening Tool of Older Persons’potentiallyinappropriate Prescriptions/Screening Tool to Alert doctors to the RightTreatment) criteria: Systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther, 41, 158–169. https://doi.org/10.1111/jcpt.12372
Hussain, M. A., Huxley, R. R., & Al Mamun, A. (2015). Multimorbidity prevalence and pattern in Indonesian adults: An exploratory study using national survey data. BMJ Open, 5(12), e009810. https://doi.org/10.1136/bmjopen-2015-009810
Jaynes, M., & Kumar, A. B. (2019). The risks of long-term use of proton pump inhibitors: A critical review. Therapeutic Advances in Drug Safety, 10, 204209861880992. https://doi.org/10.1177/2042098618809927
Jung, S. J., Kim, B. J., Kim, C. K., Shim, S. R., & Jung, J.-M. (2022). Antiplatelet regimens after ischemic stroke or transient ischemic attack: A systematic review and updated network meta-analysis. Annals of Translational Medicine, 10(5), 245–245. https://doi.org/10.21037/atm-21-3748
Jungo, K. T., Streit, S., & Lauffenburger, J. C. (2021). Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications. BMC Geriatrics, 21(1), 163. https://doi.org/10.1186/s12877-021-02089-x
Koçak, F. Ö. K., Taşkıran, E., Öztürk, Z. K., & Şahin, S. (2022). Potentially Inappropriate Medication Use among Nursing Home Residents: Medication Errors Associated with Pro re nata Medications and the Importance of Pill Burden. Annals of Geriatric Medicine and Research, 26(3), 233–240. https://doi.org/10.4235/agmr.22.0096
Kojima, T. (2018). The Need for Actions Against Polypharmacy in Older People With Frailty. Annals of Geriatric Medicine and Research, 22(3), 111–116. https://doi.org/10.4235/agmr.2018.22.3.111
Komagamine, J. (2018). Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: A retrospective cross-sectional study. BMJ Open, 8(7), e021152. https://doi.org/10.1136/bmjopen-2017-021152
Lemeshow, S., Hosmer, D. W., Klar, J., & Lwanga, S. K. (1990). Adequacy of Sample Size in Health Studies. John Wiley & Sons.
Lisowska, A., Czepielewska, E., Rydz, M., Dworakowska, A., Makarewicz-Wujec, M., & Kozłowska-Wojciechowska, M. (2022). Applicability of tools to identify potentially inappropriate prescribing in elderly during medication review: Comparison of STOPP/START version 2, Beers 2019, EU(7)-PIM list, PRISCUS list, and Amsterdam tool—A pilot study. PLOS ONE, 17(9), e0275456. https://doi.org/10.1371/journal.pone.0275456
Liu, L., Jia, L., Jian, P., Zhou, Y., Zhou, J., Wu, F., & Tang, Y. (2020). The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies. Frontiers in Psychiatry, 11, 00755. https://doi.org/10.3389/fpsyt.2020.00755
Louvet, S., Ischayek, M., & Danoff, R. (2015). The Current Role of Long-Term Benzodiazepines for the Treatment of Generalized Anxiety. Osteopathic Family Physician, 7(1).
M. Meraya, A., Alwhaibi, M., H Syed, M., Shwihi, A., Mashraqi, M., Tripathi, R., Buayti, Y., & Moraya, D. (2020). Utilization of Psychotropic Medications and Polypharmacy Among Adults in Jazan Region, Saudi Arabia. Indonesian Journal of Pharmacy, 205. https://doi.org/10.22146/ijp.813
Ma, Z., Zhang, C., Cui, X., & Liu, L. (2018). Comparison of three criteria for potentially inappropriate medications in Chinese older adults. Clinical Interventions in Aging, Volume 14, 65–72. https://doi.org/10.2147/CIA.S190983
Magalhães, M. S., Santos, F. S. dos, & Reis, A. M. M. (2019). Factors associated with the use of potentially inappropriate medication by elderly patients prescribed at hospital discharge. Einstein (São Paulo), 18, eAO4877. https://doi.org/10.31744/einstein_journal/2020AO4877
Masudo C., Ogawa Y., Yamashita N., & Mihara K. (2019). Association between Elimination Half-life of Benzodiazepines and Falls in the Elderly: A Meta-analysis of Observational Studies. YAKUGAKU ZASSHI, 139(1), 113–122. https://doi.org/10.1248/yakushi.18-00156
Miller, G. E., Sarpong, E. M., Davidoff, A. J., Yang, E. Y., Brandt, N. J., & Fick, D. M. (2017). Determinants of Potentially Inappropriate Medication Use among Community-Dwelling Older Adults. Health Services Research, 52(4), 1534–1549. https://doi.org/10.1111/1475-6773.12562
Monteiro, C., Silvestre, S., Duarte, A. P., & Alves, G. (2022). Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. International Journal of Environmental Research and Public Health, 19(6), 3541. https://doi.org/10.3390/ijerph19063541
Nurmainah, N., & Astuti, R. (2022). Detection of Potentially Inappropriate Medication in Elderly Outpatient Based on The Beer’s Criteria 2019. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA, 9(1), 82–91. https://doi.org/10.20473/jfiki.v9i12022.82-91
Oliveira, M. G., Amorim, W. W., de Jesus, S. R., Heine, J. M., Coqueiro, H. L., & Passos, L. C. S. (2015). A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care: Beers or STOPP criteria in primary care. Journal of Evaluation in Clinical Practice, 21(2), 320–325. https://doi.org/10.1111/jep.12319
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan, C., & Gallagher, P. (2014). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age and Ageing, 44(2), 213–218. https://doi.org/10.1093/ageing/afu145
Pergolizzi, J. V., & LeQuang, J. A. (2020). Reappraising the use of benzodiazepines in chronic pain patients. Postgraduate Medicine, 132(sup3), 10–12. https://doi.org/10.1080/00325481.2020.1725352
Perpétuo, C., Plácido, A. I., Rodrigues, D., Aperta, J., Piñeiro-Lamas, M., Figueiras, A., Herdeiro, M. T., & Roque, F. (2021). Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria. Frontiers in Pharmacology, 12, 676020. https://doi.org/10.3389/fphar.2021.676020
Rahmawati, F., Mustafidah, N., Pramantara, I. D. P., & Wahab, I. A. (2019). A Study of Psychoactive Medicines and Risk of Falls Among Indonesian Elderly Patients. Indonesian Journal of Pharmacy, 30(3), 233. https://doi.org/10.14499/indonesianjpharm30iss3pp233
Reimers, M., Eriksdotter, M., Seiger, Å., & Fastbom, J. (2018). Prescription Changes During Geriatric Care Episodes: A Trend Analysis Conducted in Sweden. Drugs & Aging, 35(3), 243–248. https://doi.org/10.1007/s40266-017-0509-z
Renom-Guiteras, A., Meyer, G., & Thürmann, P. A. (2015). The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries. European Journal of Clinical Pharmacology, 71(7), 861–875. https://doi.org/10.1007/s00228-015-1860-9
Salive, M. E. (2013). Multimorbidity in Older Adults. Epidemiologic Reviews, 35(1), 75–83. https://doi.org/10.1093/epirev/mxs009
Samara, M. T., Huhn, M., Chiocchia, V., Schneider‐Thoma, J., Wiegand, M., Salanti, G., & Leucht, S. (2020). Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: A systematic review and network meta‐analysis. Acta Psychiatrica Scandinavica, 142(1), 6–17. https://doi.org/10.1111/acps.13201
San-José, A., Agustí, A., Vidal, X., Formiga, F., Gómez-Hernández, M., García, J., López-Soto, A., Ramírez-Duque, N., Torres, O. H., Barbé, J., & on behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project. (2015). Inappropriate prescribing to the oldest old patients admitted to hospital: Prevalence, most frequently used medicines, and associated factors. BMC Geriatrics, 15(1), 42. https://doi.org/10.1186/s12877-015-0038-8
Sheth, A., Dave, R., Rana, D., & Sheth, D. (2020). Comparison of the extent and prevalence of prescription of potentially inappropriate medications prescribed to geriatric age group residing in old-age homes versus those receiving care from tertiary care hospital using Beers criteria. Perspectives in Clinical Research, 11(4), 144. https://doi.org/10.4103/picr.PICR_144_18
Soejono, C. H., & Rizka, A. (2021). Polypharmacy and Drug Use Pattern among Indonesian Elderly Patients Visiting Emergency Unit. Acta Med Indones, 53(1).
Tian, F., Chen, Z., & Wu, J. (2022). Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 13, 862561. https://doi.org/10.3389/fphar.2022.862561
Veronese, N., Demurtas, J., Thompson, T., Solmi, M., Pesolillo, G., Celotto, S., Barnini, T., Stubbs, B., Maggi, S., Pilotto, A., Onder, G., Theodoratou, E., Vaona, A., Firth, J., Smith, L., Koyanagi, A., Ioannidis, J. P. A., & Tzoulaki, I. (2020). Effect of low‐dose aspirin on health outcomes: An umbrella review of systematic reviews and meta‐analyses. British Journal of Clinical Pharmacology, 86(8), 1465–1475. https://doi.org/10.1111/bcp.14310
Villa-Zapata, L., Carhart, B. S., Horn, J. R., Hansten, P. D., Subbian, V., Gephart, S., Tan, M., Romero, A., & Malone, D. C. (2021). Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis. American Journal of Health-System Pharmacy, 78(24), 2245–2255. https://doi.org/10.1093/ajhp/zxab215
Viviandhari, D., Nurhasnah, N., Sakinah, R. N., & Wulandari, D. (2022). A Comparison of Potentially Inappropriate Medications Identification Using Beers and STOPP Criteria in Hospitalized Geriatric Patients in Jakarta. Indonesian Journal of Clinical Pharmacy, 11(2), 105–115. https://doi.org/10.15416/ijcp.2022.11.2.105
Viviandhari, D., Wulandari, N., Rusdi, N. K., Rahmi, N., Hildayana, N., & Faniroh, N. S. S. (2020). Assessing Potentially Inappropriate Medications in Hospitalized Geriatric Patients in 2 Hospital in Jakarta using STOPP START Criteria. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 10(1). https://doi.org/10.22146/jmpf.48944
Weir, R. A. P., McMurray, J. J. V., Puu, M., Solomon, S. D., Olofsson, B., Granger, C. B., Yusuf, S., Michelson, E. L., Swedberg, K., Pfeffer, M. A., & CHARM Investigators. (2008). Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa. European Journal of Heart Failure, 10(2), 157–163. https://doi.org/10.1016/j.ejheart.2007.12.006
Witenko, C., Moorman-Li, R., Motycka, C., Duane, K., Hincapie-Castillo, J., Leonard, P., & Valaer, C. (2014). Considerations for the Appropriate Use of Skeletal Muscle Relaxants for the Management Of Acute Low Back Pain. Pharmacy and Therapeutics, 39(6), 427–435.
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018). A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging and Disease, 9(1), 143. https://doi.org/10.14336/AD.2017.0306
Wulansari, A., Wiedyaningsih, C., & Probosuseno, P. (2023). Potentially Inappropriate Medication (PIM) pada Pasien Geriatri Rawat Inap di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Majalah Farmaseutik, 19(1), 91. https://doi.org/10.22146/farmaseutik.v19i1.70420
Zhang, H., Wong, E. L., Wong, S. Y., Chau, P. Y., Yip, B. H., Chung, R. Y., Lee, E. K., Lai, F. T., & Yeoh, E.-K. (2021). Prevalence and determinants of potentially inappropriate medication use in Hong Kong older patients: A cross-sectional study. BMJ Open, 11(7), e051527. https://doi.org/10.1136/bmjopen-2021-051527
Published
2025-03-27
How to Cite
Fita Rahmawati, Maharani, L., Ikawati, Z., & Mustofa. (2025). Potentially Inappropriate Medications (PIMs) in Geriatric Outpatients Prescriptions in Yogyakarta: Pattern and Factors Related to Occurrences. Indonesian Journal of Pharmacy. https://doi.org/10.22146/ijp.12864
Issue
Section
Research Article
